Repligen Corporation
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
6,319.73
0.02 EUR
−24.65 M EUR
612.85 M EUR
53.22 M
About Repligen Corporation
Sector
Industry
CEO
Olivier Dominique Loeillot
Website
Headquarters
Waltham
Founded
1981
Identifiers
3
ISIN US7599161095
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RGN is 140.70 EUR — it has decreased by −0.61% in the past 24 hours. Watch Repligen Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Repligen Corporation stocks are traded under the ticker RGN.
RGN stock has fallen by −3.35% compared to the previous week, the month change is a 2.86% rise, over the last year Repligen Corporation has showed a −6.82% decrease.
We've gathered analysts' opinions on Repligen Corporation future price: according to them, RGN price has a max estimate of 189.10 EUR and a min estimate of 137.53 EUR. Watch RGN chart and read a more detailed Repligen Corporation stock forecast: see what analysts think of Repligen Corporation and suggest that you do with its stocks.
RGN stock is 1.92% volatile and has beta coefficient of 1.30. Track Repligen Corporation stock price on the chart and check out the list of the most volatile stocks — is Repligen Corporation there?
Today Repligen Corporation has the market capitalization of 7.83 B, it has decreased by −1.06% over the last week.
Yes, you can track Repligen Corporation financials in yearly and quarterly reports right on TradingView.
Repligen Corporation is going to release the next earnings report on Feb 25, 2026. Keep track of upcoming events with our Earnings Calendar.
RGN earnings for the last quarter are 0.39 EUR per share, whereas the estimation was 0.36 EUR resulting in a 9.11% surprise. The estimated earnings for the next quarter are 0.37 EUR per share. See more details about Repligen Corporation earnings.
Repligen Corporation revenue for the last quarter amounts to 160.90 M EUR, despite the estimated figure of 155.24 M EUR. In the next quarter, revenue is expected to reach 164.23 M EUR.
RGN net income for the last quarter is 12.71 M EUR, while the quarter before that showed 12.62 M EUR of net income which accounts for 0.69% change. Track more Repligen Corporation financial stats to get the full picture.
No, RGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 15, 2026, the company has 1.78 K employees. See our rating of the largest employees — is Repligen Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Repligen Corporation EBITDA is 145.65 M EUR, and current EBITDA margin is 17.21%. See more stats in Repligen Corporation financial statements.
Like other stocks, RGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Repligen Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Repligen Corporation technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Repligen Corporation stock shows the buy signal. See more of Repligen Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.